Clinical Trial

A Study of GQ1010 in Subjects With Advanced Solid Tumors

Name: A Study of GQ1010 in Subjects With Advanced Solid Tumors — clinical trial record (NCT06464055)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is an open-label, phase I/II study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of GQ1010 and preliminary anti-tumor efficacy in advanced malignant solid tumor subjects

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2024-06-12.

Trial Details

NCT Number	NCT06464055
Lead Sponsor	GeneQuantum Healthcare (Suzhou) Co., Ltd.
Conditions	Advanced Malignant Solid Tumors
Enrollment	260 participants
Start Date	2024-05-23
Primary Completion	2028-05-23 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-02-10